Loading…
This event has ended. Create your own event on Sched.
Whether you are a gastroenterologist or allied health professional treating patients with Inflammatory Bowel Disease, Advances in IBD is the most important meeting you will attend all year. Our agenda is focused on providing the most practical and evidence-based education available to help you improve the lives of your patients suffering from IBD.
avatar for James Lindsay, MD

James Lindsay, MD

Barts Health NHS Trust
London, United Kingdom
James Lindsay is the Professor of Inflammatory Bowel Disease at Barts and the London School of Medicine and Dentistry, Queen Mary University of London and a Consultant Gastroenterologist at Barts Health NHS Trust. Along with a full multidisciplinary team he runs the adolescent and adult IBD service at The Royal London Hospital.

He is the Education Officer and a member of the Governing Board of the European Crohn’s and Colitis Organisation (ECCO). He is also the ECCO e-learning ambassador and past chair of the ECCO Education Committee. He has chaired working groups for the ECCO consensus on the management of Crohn’s disease and ulcerative colitis. He is the British Society of Gastroenterology (BSG) national societies representative to United European Gastroenterology.

Professor Lindsay serves on the BSG IBD Clinical Trials Steering Group and is Chief Investigator for a series of investigator-led and commercial clinical trials in IBD. He leads the NIHR funded ASTIClite trial which will assess the efficacy, safety and mechanism of action of low intensity autologous stem cell transplantation in patients with refractory Crohn’s disease. In addition, he leads a program of translational science research.